Company: PCRX
Filing Date: 2025-04-22
Form Type: 8-K
Source: 0001396814-25-000055
Chunk: 0

Company: Pacira BioSciences, Inc.
Filing Date: 2025-04-22
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01. Other Events.

On April 17, 2025, Pacira BioSciences, Inc. (the “ Company”) announced that its Board of Directors has approved a new share repurchase program, effective immediately, which authorizes the Company to purchase up to an aggregate of $300.0 million of the Company’s outstanding common stock, which replaces the Company’s previous share repurchase program announced on May 7, 2024. Repurchases under this program may be made at management’s discretion on the open market or through privately negotiated transactions. The share repurchase program may be suspended or discontinued at any time by the Company and has an expiration date of December 31, 2026.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                           PACIRA BIOSCIENCES, INC.                    
  Dated:      April 22, 2025      By:      /s/ KRISTEN WILLIAMS                        
                                           Kristen Williams                            
                                           Chief Administrative Officer and Secretary